Immugenia Revenue and Competitors
Estimated Revenue & Valuation
- Immugenia's estimated annual revenue is currently $310k per year.
- Immugenia's estimated revenue per employee is $77,500
Employee Data
- Immugenia has 4 Employees.
- Immugenia grew their employee count by -20% last year.
Immugenia's People
| Name | Title | Email/Phone |
|---|
Immugenia Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $81.4M | 375 | 40% | N/A | N/A |
#2 | $16.9M | 109 | 22% | N/A | N/A |
#3 | $156.1M | 120 | -70% | $145M | N/A |
#4 | $2.9M | 37 | -24% | $150M | N/A |
#5 | $1.3M | 17 | 0% | $459.5M | N/A |
#6 | $49.2M | 254 | 15% | $180.7M | N/A |
#7 | $7M | 45 | -2% | N/A | N/A |
#8 | $256.3M | 840 | 9% | $168.5M | N/A |
#9 | $4.2M | 27 | -7% | N/A | N/A |
#10 | $10.1M | 65 | 5% | N/A | N/A |
What Is Immugenia?
Immugenia Inc. is a preclinical stage immuno-oncology company developing the next generation CAR therapy to treat and prevent relapses in hematological and solid tumors. This is achieved by engineering hematopoietic stem cells using proprietary specific promoters (SPICA) to express CAR in select immune cells leveraging the synergistic activity of T and NK cells. This provides patients with a one-and-done treatment to fight hard-to-treat cancers and prevent relapses.
keywords:N/A
N/A
Total Funding
4
Number of Employees
$310k
Revenue (est)
-20%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Other Companies in
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $0.7M | 4 | -20% | N/A |
#2 | $0.5M | 4 | -20% | N/A |
#3 | $0.5M | 4 | -20% | N/A |
#4 | $0.3M | 4 | N/A | N/A |
#5 | $0.3M | 4 | N/A | N/A |